At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Ambulight (Ambicare Health)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Assessor-blinded Comparison of Low Irradiance and Conventional Irradiance Photodynamic Therapy (PDT) for Superficial Non-melanoma Skin Cancer
In Brief
A clinical study evaluating Ambulight (Ambicare Health) for Non-melanoma Skin Cancer. Completed, enrolled 50 participants.
Detailed Summary
This study aims to examine whether the pain of topical photodynamic therapy (PDT) is significantly different when using low irradiance ambulatory light emitting diode (LED) devices compared with conventional higher irradiance hospital based LED light sources when used for superficial non-melanoma skin cancer. The investigators are also investigating the phototoxicity and efficacy of each regime in this randomized assessor-blinded clinical trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-melanoma Skin Cancer
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
First PostedAug 2016
Primary CompletionFeb 2017
TodayJul 2026
First PostedAug 19, 2016
Enrollment StartOct 1, 2011
Primary CompletionFeb 6, 2017
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 9.9 years ago
Interventions
Ambulight (Ambicare Health)device
battery-operated low irradiance red light LED ("skin cancer plaster")